Age, Biography and Wiki
Tom Frieden was born on 7 December, 1960 in New York, NY, is an American physician. Discover Tom Frieden's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 63 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
63 years old |
Zodiac Sign |
Sagittarius |
Born |
7 December, 1960 |
Birthday |
7 December |
Birthplace |
New York City, New York, U.S. |
Nationality |
United States |
We recommend you to check the complete list of Famous People born on 7 December.
He is a member of famous with the age 63 years old group.
Tom Frieden Height, Weight & Measurements
At 63 years old, Tom Frieden height not available right now. We will update Tom Frieden's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Who Is Tom Frieden's Wife?
His wife is Barbara Chang
Family |
Parents |
Not Available |
Wife |
Barbara Chang |
Sibling |
Not Available |
Children |
Not Available |
Tom Frieden Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Tom Frieden worth at the age of 63 years old? Tom Frieden’s income source is mostly from being a successful . He is from United States. We have estimated
Tom Frieden's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Tom Frieden Social Network
Timeline
In June 2019, Frieden pled guilty to disorderly conduct in New York City. In 2018 he faced misdemeanor charges of forcible touching, third-degree sexual abuse and second-degree harassment, which were dropped. Frieden issued a statement shortly after his arrest, stating the allegation "does not reflect" his "public or private behavior or his values."
In May 2009, the White House and the Department of Health and Human Services named Frieden director of the Centers for Disease Control and Prevention and administrator of the Agency for Toxic Substances and Disease Registry; positions he assumed in June 2009, from the acting head Richard E. Besser. Frieden resigned effective January 20, 2017.
Frieden was prominently involved in the US and global response to the West African outbreak of Ebola. His visits to West Africa beginning in August 2014 and a September 2014 CDC analysis projecting that the Ebola epidemic could increase exponentially to infect more than 1 million people within four months prompted him to press for an international surge response. At the peak of the response, CDC maintained approximately 200 staff per day in West Africa and about 400 staff per day at its Atlanta headquarters; overall, about 1,900 CDC staff deployed to international and U.S. locations for about 110,000 total work days, and more than 4,000 CDC staff worked as part of the response. In a Congressional hearing in October 2014, Frieden was asked about his handling of the Ebola crisis after the disease had spread to two nurses from a patient in the US. The day prior, Rep. Tom Marino (R-PA) had called for Frieden's resignation, though others rallied to his defense.
He was the director of the U.S. Centers for Disease Control and Prevention (CDC), and he was the administrator of the Agency for Toxic Substances and Disease Registry from 2009 to 2017, appointed by President Barack Obama.
Frieden introduced the city's first comprehensive health policy, Take Care New York, which targeted ten leading causes of preventable illness and death for public and personal action. By 2007, New York City had made measurable progress in eight of the ten priority areas.
As Health Commissioner, Frieden sought to fight HIV and AIDS with public health principles used successfully to control other communicable diseases. A very controversial aspect was the proposal to eliminate separate written consent for HIV testing. He believed the measure would encourage physicians to offer HIV tests during routine medical care, as the CDC recommended. Some community and civil liberties advocates fought this legislation, arguing it would undermine patients' rights and lead eventually to forced HIV testing. In 2010, New York State passed a new law that eased the requirement for separate written consent in some circumstances. Frieden's perspective is now widely accepted, and on February 14, 2007, the New York City Department of Health and Mental Hygiene introduced the NYC Condom, prompting Catholic League president Bill Donohue to respond, "What's next? The city's own brand of clean syringes?" More than 36 million condoms were given away by the program in 2007.
In September 2006, the city proposed to restrict trans fat served in New York restaurants. New York City's trans fat ban followed mandatory labeling of trans fat by the Food and Drug Administration (FDA), was credited with saving lives and preceded by more than a decade the FDA's action to ban trans fat from food throughout the United States.
As a commissioner of the New York City Department of Health and Mental Hygiene from 2002 to 2009 he came to some prominence for banning smoking and trans fat served in the city's restaurants.
Frieden served as Commissioner of Health of the City of New York from 2002 to 2009. At the time of his appointment, the agency employed 6,000 staff and had an annual budget of $1.6 billion. During Frieden's tenure as Commissioner, the Health Department expanded the collection and use of epidemiological data, launching an annual Community Health Survey and the nation's first community-based Health and Nutrition Examination Survey.
Upon his appointment as Commissioner of Health, Frieden made tobacco control a priority, resulting in a rapid decline after a decade of no change in smoking rates. Frieden established a system to monitor the city's smoking rates, and worked with New York City Mayor Michael R. Bloomberg to increase tobacco taxes, ban smoking in workplaces including restaurants and bars, and run aggressive anti-tobacco ads and help smokers quit. The program reduced smoking prevalence among New York City adults from 21% in 2002 to 17% in 2007 which represented 300,000 fewer smokers. Smoking prevalence among New York City teens declined even more sharply, from 17.6% in 2001 to 8.5% in 2007, which was less than half the national rate. The workplace smoking ban prompted spirited debate before the New York City Council passed it and Mayor Bloomberg signed it into law. Over time, the measure gained broad acceptance by the public and business community in New York City. New York City's 2003 workplace smoking ban followed that of California in 1994. Frieden supported increased cigarette taxes as a means of reducing smoking and preventing teens from starting, saying "tobacco taxes are the most effective way to reduce tobacco use." He supported the 62-cent federal tax on each cigarette pack sold in the United States, introduced in April 2009. One side effect of the increased taxes on tobacco in New York was a large increase in cigarette smuggling into the state from other states with much lower taxes, such as Virginia. The Tax Foundation estimated that "60.9% of cigarettes sold in New York State are smuggled in from other states". In addition, some New Yorkers began to make their own cigarettes, and tobacco trucks were even hijacked. A 2009 Justice Department study found that "The incentive to profit by evading payment of taxes rises with each tax rate hike imposed by federal, state, and local governments".
From 1995 to 2001, Frieden worked as a technical advisor for the World Bank, health and population offices. From 1996 to 2002, Frieden worked in India, as a medical officer for the World Health Organization on loan from the CDC. He helped the government of India implement the Revised National Tuberculosis Control Program. The program's 2008 status report estimated that the nationwide program resulted in 8 million treatments and 1.4 million lives saved. While in India, Frieden worked to establish a network of Indian physicians to help India's state and local governments implement the program and helped the Tuberculosis Research Center in Chennai, India, establish a program to monitor the impact of tuberculosis control services.
From 1990 to 1992, Frieden worked as an Epidemic Intelligence Service officer assigned by CDC in New York City. From 1992 to 1996, he was assistant commissioner of health and director of the New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, fostering public awareness and helping to improve city, state and federal public funding for TB control. The New York City epidemic was controlled rapidly, reducing overall incidence by nearly half and cutting multidrug-resistant tuberculosis by 80%. The city's program became a model for tuberculosis control nationally and globally.
Frieden was born and raised in New York City. His father, Julian Frieden, was chief of coronary care at Montefiore Hospital and New Rochelle Hospitals in New York. He is of Jewish ancestry. Frieden attended Oberlin College graduating with a BA in philosophy in 1982. He was a community organizer for the Center for Health Services at Vanderbilt University in 1982, before he started studying medicine at Columbia University College of Physicians and Surgeons and graduated in 1986. At the same time he attended Columbia University Mailman School of Public Health and obtained an MPH in 1986. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center 1986–1989 followed by a one-year infectious diseases fellowship from 1989–1990 at Yale School of Medicine and Yale–New Haven Hospital.
Thomas R. Frieden (born December 7, 1960) is an American infectious disease and public health physician. He serves as President and CEO of Resolve to Save Lives, a $225 million, five-year initiative to prevent epidemics and cardiovascular disease.